Skip to main content

Advertisement

SpringerLink
Log in

The rollercoaster ride to anti-cancer antibodies

  • News & Views
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

A recent Keystone meeting highlighted the progress in developing antibody-based therapeutics for cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: IgG antibody—a versatile platform for anti-cancer therapeutics.

References

  1. Köhler, G. & Milstein, C. Nature 256, 495–497 (1975).

    Article  Google Scholar 

  2. Keystone Symposium: Antibody-Based Therapeutics for Cancer, Banff Centre, Banff, Alberta, Canada, February 4–9, 2003.

  3. Clynes, R.A., Towers, T.L., Presta, L.G. & Ravetch, J.V. Nat. Medicine 6, 443–446 (2000).

    Article  CAS  Google Scholar 

  4. Clynes, R., Takechi, Y., Moroi, Y., Houghton, A. & Ravetch, J.V. Proc. Natl. Acad. Sci. USA 95, 652–656 (1998).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Medical Oncology, Fox Chase Cancer Center, Philadelphia, 19111, PA

    Louis M. Weiner & Paul Carter

  2. Antibody Technologies, Seattle Genetics, Seattle, 98021, WA

    Louis M. Weiner & Paul Carter

Authors
  1. Louis M. Weiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul Carter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weiner, L., Carter, P. The rollercoaster ride to anti-cancer antibodies. Nat Biotechnol 21, 510–511 (2003). https://doi.org/10.1038/nbt0503-510

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0503-510

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation